BOLANLE O. IRANLOYE

BOLANLE O. IRANLOYE

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2026 in Journal of Blood Medicine
Verified
Journal Article
Open access
PDF file
SRStella Samson Rwezaula
Stella Samson Rwezaula
SMSamson D Mtoba
Samson D Mtoba
JMJohnny Mahlangu
Johnny Mahlangu
AMAmos Rodger Mwakigonja
Amos Rodger Mwakigonja
BIBOLANLE O. IRANLOYE
BOLANLE O. IRANLOYE
OAOluyemi Akinloye
Oluyemi Akinloye
Background: Haemophilia is a rare inherited bleeding disorder associated with recurrent bleeding, disability, and mortality when diagnosis and management are delayed. In low- and middle-income countries, limited diagnostic capacity, access to treatment and gaps in Healthcare Providers’ (HCPs’) knowledge are major contributors to morbidity and mortality. In Tanzania, the recent improvement in haemophilia services highlights the need for systematic evaluation of HCPs’ knowledge and clinical practices. Objective: The study assessed the knowledge of haemophilia care among healthcare providers in Tanzania. Methods: A multicenter hospital-based cross-sectional study was conducted among HCPs in tertiary and regional hospitals in Tanzania. A structured self-administered questionnaire assessed knowledge on haemophilia, including the pathophysiology, clinical features, diagnosis, treatment, and complications. Data were analyzed using IBM SPSS statistics version 27. Results: Among 799 HCPs assessed (50.9%) aged 20– 29 and (59.2%) males. Nurses were the majority (31.8%), and 75.2% had ≤ 5 years’ experience. Overall haemophilia knowledge was high (median 83.3%, IQR: 75.9– 88.9), strongest performance in general knowledge and weakest in treatment (68.2%, IQR: 54.5– 77.3). Most respondents identified haemophilia as inherited (95.6%), non-infectious (93.7%), and recognized prolonged bleeding after injury or circumcision as key-symptoms (> 90%). Knowledge varied by cadre, department, and experience (p< 0.05); physicians and specialists scored higher than nurses, while health attendants scored lower. Conclusion: Healthcare providers demonstrated fairly adequate general knowledge of haemophilia. However, gaps remain in understanding genetic inheritance, acquired haemophilia, and modern treatment strategies, with knowledge variation by cadre, department, and experience, highlighting the need for targeted education across all HCPs groups.

30 September 2026 in Endocrines
Verified
Journal Article
Open access
PDF file
OBOlabimpe Caroline Badejogbin
Olabimpe Caroline Badejogbin
GOGabriel O. Oludare
Gabriel O. Oludare
BIBOLANLE O. IRANLOYE
BOLANLE O. IRANLOYE
Background: Diabetes in males leads to hyperglycemia-induced oxidative stress and inflammation in the testis, resulting in apoptosis. Diabetes-induced testicular impairment has been linked to the implication with the gut–brain axis. Sodium butyrate, a product of the gut microbiota fermentation process, has been targeted for its anti-diabetic, anti-inflammatory, and antioxidative functions. This research, therefore, explored sodium butyrate as a therapeutic potential intervention in mitigating diabetes-induced testicular dysfunction. Methods: Thirty-five male rats were randomly assigned to five groups after diabetes was confirmed: healthy control (CON), sodium butyrate-treated (SBUT; 200 mg/kg orally), diabetic control (T1DM; 50 mg/kg STZ intraperitoneally), diabetes + sodium butyrate (T1DM + SBUT), and diabetes + insulin (T1DM + INSL, 0.9 I.U/100 g/day). Body weight, testicular weight, glucose homeostasis (fasting blood sugar, oral glucose tolerance, and glycated hemoglobin), lipid profile, testosterone level, sperm analysis, histopathology of the testis, and anti-apoptotic markers (B-cell lymphoma-2 (Bcl-2), Bcl-associated protein X (Bax), and Caspase-3) were all assessed. Results: Along with elevated blood glucose and glycated hemoglobin levels, diabetic rats showed a notable decrease in body weight, testicular mass, gonadosomatic index, sperm count, motility, viability, and normal morphology. Elevated Bax and Caspase-3 expression with reduced Bcl-2 were observed alongside testicular fibrosis, accumulation of collagen, and carbohydrate-rich substances. Sodium butyrate treatment, by downregulating Bax and Caspase-3 and upregulating Bcl-2, conserved testicular histoarchitecture, restored sperm quality, controlled apoptotic signaling, and markedly improved metabolic indices. Conclusions: Sodium butyrate displayed a protective role in the testis in diabetic conditions via the modulation of hyperglycemia-induced apoptosis, identifying this as a potential therapeutic intervention in diabetes-induced testicular dysfunction.

27 October 2022 in Endocrine Abstracts
Verified
Journal Article
Closed access
ASAina Olawale Samson
Aina Olawale Samson
BIBOLANLE O. IRANLOYE
BOLANLE O. IRANLOYE
ECEvangelshane Ckukwuduben
Evangelshane Ckukwuduben
ARAdebayo Rotimi
Adebayo Rotimi
Endocrine therapy in hormone sensitive cancers is on the increase and substances that reduce estrogen level and upregulate estrogen receptor can reduce activities of ovarian cancer. Clomiphene citrate (CC) is a selective estrogen receptor modulator. This study is aimed at investigating how different doses of CC affect estrogen level and level of alpha and beta estrogen receptors in the ovary of adult female rats. Fifty female Sprague-Dawley (SD) rats were divided into 5 groups of 10 rats each. Group A (control) received sterile water. Groups B, C, D received 0.2 mg/kg, 2 mg/kg, 4 mg/kg of CC dissolved in distilled water at diestrus respectively. Group E was given 6 mg/kg of CC dissolved in distilled water daily via oral administration. Estrous cycle was monitored daily and the phases recorded. Serum analysis of estrogen level was done alongside the estrogen alpha (ERa) and estrogen receptor beta (ERb) levels after ovarian homogenization at different phases of the estrus cycle. In all the phases, CC caused a significant decrease (P<0.05) in estrogen level for groups D and E compared with control. Groups B and C showed significant (P0.05) for groups B and C at proestrus and estrus phases but there is a dose-dependence changes at metestrus and diestrus in the treated groups (B, C, D, and E). Group B showed a significant decrease (P<0.05) in ERb across the phases compared with control. Meanwhile, ERb it significantly increased (P<0.05) in all the phases for Group E compared with control. Clomiphene citrate reduced the estrogen level and increase ERb at high dose. This shows that high doses of clomiphene could be useful as an adjunct in the management of ovarian cancer.